Literature DB >> 3257726

Torsade de pointes in a patient receiving intravenous vasopressin.

V F Mauro1, J F Bingle, S M Ginn, F M Jafri.   

Abstract

A patient experienced hypertension, bradycardia, QT prolongation, and multiple episodes of torsade de pointes while receiving an iv vasopressin infusion. The dysrhythmias were attributed to vasopressin, but may have been potentiated by hypomagnesemia. Upon vasopressin discontinuation, ECG findings returned to normal before magnesium supplementation. Vasopressin may contribute to the development of torsade de pointes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257726     DOI: 10.1097/00003246-198802000-00020

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

Review 1.  Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Arrhythmia in a 38-year-old man.

Authors:  T P Ip; C P Lau; K S Lam
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

Review 3.  The use of vasopressin in the treatment of upper gastrointestinal haemorrhage.

Authors:  D L Stump; T C Hardin
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

4.  Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?

Authors:  Pierre Asfar; Peter Radermacher
Journal:  Crit Care       Date:  2009-07-22       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.